Details for New Drug Application (NDA): 217740
✉ Email this page to a colleague
NDA 217740 describes TRAZODONE HYDROCHLORIDE, which is a drug marketed by Accord Hlthcare, Alvogen, Am Therap, Apotex, Apotex Inc, Aurobindo Pharma, Crossmedika Sa, Fosun Pharma, Granules, Graviti Pharms, Natco, Norvium Bioscience, Oxford Pharms, Pliva, Quantum Pharmics, Rising, Sun Pharm Industries, Teva, Teva Pharms Usa, Torrent, Usl Pharma, Watson Labs, and Zydus Pharms, and is included in thirty-two NDAs. It is available from thirty-eight suppliers. Additional details are available on the TRAZODONE HYDROCHLORIDE profile page.
The generic ingredient in TRAZODONE HYDROCHLORIDE is trazodone hydrochloride. There are fourteen drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the trazodone hydrochloride profile page.
The generic ingredient in TRAZODONE HYDROCHLORIDE is trazodone hydrochloride. There are fourteen drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the trazodone hydrochloride profile page.
Summary for 217740
| Tradename: | TRAZODONE HYDROCHLORIDE |
| Applicant: | Graviti Pharms |
| Ingredient: | trazodone hydrochloride |
| Patents: | 0 |
Suppliers and Packaging for NDA: 217740
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| TRAZODONE HYDROCHLORIDE | trazodone hydrochloride | TABLET;ORAL | 217740 | ANDA | Graviti Pharmaceuticals Private Limited | 69844-087 | 69844-087-01 | 100 TABLET in 1 BOTTLE (69844-087-01) |
| TRAZODONE HYDROCHLORIDE | trazodone hydrochloride | TABLET;ORAL | 217740 | ANDA | Graviti Pharmaceuticals Private Limited | 69844-087 | 69844-087-02 | 500 TABLET in 1 BOTTLE (69844-087-02) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Aug 27, 2024 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
| Approval Date: | Aug 27, 2024 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 150MG | ||||
| Approval Date: | Aug 27, 2024 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
